During the past decade, Azienda Ospedaliero-Universitaria Careggi; SOD Radioterapia conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliero-Universitaria Careggi; SOD Radioterapia" are "Breast Cancer" (3 trials), "Triple-Negative Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Hepatocellular Carcinoma" (1 trials) and "Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)" (1 trials). Many other conditions were trialed in "Azienda Ospedaliero-Universitaria Careggi; SOD Radioterapia" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliero-Universitaria Careggi; SOD Radioterapia" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (6 trials), "Placebo" (4 trials), "Capecitabine" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials) and "Atezolizumab Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliero-Universitaria Careggi; SOD Radioterapia" are 8 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda Ospedaliero-Universitaria Careggi; SOD Radioterapia". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Azienda Ospedaliero-Universitaria Careggi; SOD Radioterapia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliero-Universitaria Careggi; SOD Radioterapia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".